ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.13058del (p.Pro4353fs)

dbSNP: rs1408345511
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
CeGaT Center for Human Genetics Tuebingen RCV000512814 SCV000609007 likely pathogenic not provided 2017-05-01 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000826188 SCV000967732 likely pathogenic Primary dilated cardiomyopathy 2017-06-09 criteria provided, single submitter clinical testing The p. Pro4115GlnfsX14 (NM_133432.3 c.12344delC) variant in TTN has not been pre viously reported in individuals with dilated cardiomyopathy (DCM). It has been i dentified in 1/111050 European chromosomes by the genome Aggregation Database (g nomAD, http://gnomad.broadinstitute.org). This variant is predicted to cause a f rameshift, which alters the protein?s amino acid sequence beginning at position 4115 and leads to a premature termination codon 14 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Frameshif t and other truncating variants in TTN are strongly associated with DCM if they are located in the exons encoding for the A-band (Herman 2012, Pugh 2014) and/or are located in an exon that is highly expressed in the heart (Roberts 2015). Th e p. Pro4115GlnfsX14 variant is located in the I-band in the highly expressed ex on 49. In summary, although additional studies are required to fully establish i ts clinical significance, this variant is likely pathogenic.
Invitae RCV001223187 SCV001395324 likely pathogenic Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-08 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Pro4353Glnfs*14) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with TTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 444542). This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875, Invitae internal data). Truncating variants in this region have also been identified in individuals affected with autosomal dominant dilated cardiomyopathy and/or cardio-related conditions (PMID: 27869827, 32964742, Invitae internal data). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.